Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8823692rdf:typepubmed:Citationlld:pubmed
pubmed-article:8823692lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C0038013lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C0086409lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C0050403lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C0076096lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:8823692lifeskim:mentionsumls-concept:C1442461lld:lifeskim
pubmed-article:8823692pubmed:issue7lld:pubmed
pubmed-article:8823692pubmed:dateCreated1996-12-18lld:pubmed
pubmed-article:8823692pubmed:abstractTextTo compare in a 3 month, multicenter, double blind, parallel study the efficacy and safety of a nonsteroidal antiinflammatory drug, aceclofenac, 100 mg bid orally, with that of tenoxicam, 20 mg orally at bedtime, in the treatment of adult patients with active ankylosing spondylitis (AS).lld:pubmed
pubmed-article:8823692pubmed:languageenglld:pubmed
pubmed-article:8823692pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823692pubmed:citationSubsetIMlld:pubmed
pubmed-article:8823692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823692pubmed:statusMEDLINElld:pubmed
pubmed-article:8823692pubmed:monthJullld:pubmed
pubmed-article:8823692pubmed:issn0315-162Xlld:pubmed
pubmed-article:8823692pubmed:authorpubmed-author:Rico LenzaHHlld:pubmed
pubmed-article:8823692pubmed:authorpubmed-author:Villa...lld:pubmed
pubmed-article:8823692pubmed:authorpubmed-author:de BuergoMMlld:pubmed
pubmed-article:8823692pubmed:authorpubmed-author:Montull...lld:pubmed
pubmed-article:8823692pubmed:issnTypePrintlld:pubmed
pubmed-article:8823692pubmed:volume23lld:pubmed
pubmed-article:8823692pubmed:ownerNLMlld:pubmed
pubmed-article:8823692pubmed:authorsCompleteYlld:pubmed
pubmed-article:8823692pubmed:pagination1194-9lld:pubmed
pubmed-article:8823692pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:meshHeadingpubmed-meshheading:8823692-...lld:pubmed
pubmed-article:8823692pubmed:year1996lld:pubmed
pubmed-article:8823692pubmed:articleTitleAceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis.lld:pubmed
pubmed-article:8823692pubmed:affiliationRheumatology Unit, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.lld:pubmed
pubmed-article:8823692pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8823692pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8823692pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8823692pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8823692pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:8823692pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823692lld:pubmed